Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2473952926006440?dgcid=rss_sd_all
Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma. Blood Advances. https://www.sciencedirect.com/science/article/pii/S2473952926006440?dgcid=rss_sd_all
“Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma.” Blood Advances.
@article{article38196,
title = {Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2473952926006440?dgcid=rss_sd_all}
}